These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16431863

  • 1. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis.
    Petersen PJ, Labthavikul P, Jones CH, Bradford PA.
    J Antimicrob Chemother; 2006 Mar; 57(3):573-6. PubMed ID: 16431863
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J, Moreillon P, Giddey M, Entenza JM.
    J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK, Hoban DJ, Johnson BM, Johnson JL, Hsiung A, Dowzicky MJ, Tigecycline Evaluation and Surveillance Trial (TEST) Group.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [Abstract] [Full Text] [Related]

  • 4. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ.
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L, D'Arezzo S, Capone A, Petrosillo N, Visca P.
    Ann Clin Microbiol Antimicrob; 2009 May 21; 8():18. PubMed ID: 19460166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA.
    Antimicrob Agents Chemother; 2007 May 21; 51(5):1621-6. PubMed ID: 17307973
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R.
    Pharmacotherapy; 2008 Mar 21; 28(3):295-300. PubMed ID: 18294108
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ.
    Int J Antimicrob Agents; 2009 Aug 21; 34(2):121-30. PubMed ID: 19342205
    [Abstract] [Full Text] [Related]

  • 10. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.
    Entenza JM, Moreillon P.
    Int J Antimicrob Agents; 2009 Jul 21; 34(1):8.e1-9. PubMed ID: 19162449
    [Abstract] [Full Text] [Related]

  • 11. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE, Poppens PT.
    J Antimicrob Chemother; 2009 Mar 21; 63(3):485-8. PubMed ID: 19109338
    [Abstract] [Full Text] [Related]

  • 12. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Yim H, Woo H, Song W, Park MJ, Kim HS, Lee KM, Hur J, Park MS.
    Ann Clin Lab Sci; 2011 Mar 21; 41(1):39-43. PubMed ID: 21325253
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit.
    Ratnam I, Franklin C, Spelman DW.
    Pathology; 2007 Dec 21; 39(6):586-8. PubMed ID: 18027263
    [Abstract] [Full Text] [Related]

  • 14. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S, Marchese A, Debbia EA.
    Chemotherapy; 2008 Dec 21; 54(1):43-9. PubMed ID: 18073470
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C, Rodríguez-Avial I, Gómez M, Culebras E, López F, Alvarez J, Picazo JJ, Spanish Tigecycline Group.
    Diagn Microbiol Infect Dis; 2006 Dec 21; 56(4):437-44. PubMed ID: 16949245
    [Abstract] [Full Text] [Related]

  • 16. A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004-2007).
    Seifert H, Dowzicky MJ.
    Chemotherapy; 2009 Dec 21; 55(4):241-52. PubMed ID: 19468222
    [Abstract] [Full Text] [Related]

  • 17. In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay.
    Pankey GA, Ashcraft DS.
    Diagn Microbiol Infect Dis; 2009 Jul 21; 64(3):300-4. PubMed ID: 19501791
    [Abstract] [Full Text] [Related]

  • 18. Tigecycline in-vitro susceptibility and antibiotics' fitness for gram-negative pathogens.
    Arya SC, Agarwal N.
    Saudi Med J; 2008 Nov 21; 29(11):1558-60. PubMed ID: 18998000
    [Abstract] [Full Text] [Related]

  • 19. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY, Ng LS, Tan E, Huang G.
    J Antimicrob Chemother; 2007 Aug 21; 60(2):421-3. PubMed ID: 17540671
    [Abstract] [Full Text] [Related]

  • 20. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA, Almuzara MN, Rodríguez CH, Pugliese ML, Lorenzo Barba F, Mattera JC, Famiglietti AM.
    Rev Argent Microbiol; 2005 Aug 21; 37(1):34-45. PubMed ID: 15991478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.